Marie-Odile Galcera

CDC25 inhibitors as anticancer agents are moving forward.

P. Kasprzyk, G. Prévost, Marie-Odile Galcéra, 2008, Anti-cancer agents in medicinal chemistry.

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia

J. Tamburini, S. Manenti, C. Dozier, 2015, Oncotarget.

G2/M checkpoint stringency is a key parameter in the sensitivity of AML cells to genotoxic stress

B. Ducommun, S. Manenti, G. Laurent, 2008, Oncogene.